Trade with Jim Cramer 14 Days Free

Join the Action Alerts PLUS Community today!

4 Stocks Under $10 Making Big Moves

By Roberto Pedone
May 31, 2013 2:02 PM EDT

5 Stocks Insiders Love Right Now

By Jonas Elmerraji
May 9, 2013 1:30 PM EDT

3 Stocks Breaking Out on Unusual Volume

By Jonas Elmerraji
Mar 19, 2013 2:27 PM EDT

5 Stocks Set to Soar on Bullish Earnings

By Roberto Pedone
Mar 15, 2013 7:00 AM EDT

Biotech Stock Mailbag: Biogen's Alzheimer's Update, Celgene Patent Worries, Receptos, MannKind

By Adam Feuerstein
Mar 15, 2013 6:00 AM EDT

3 Stocks Breaking Out on Unusual Volume

By Roberto Pedone
Mar 8, 2013 2:20 PM EST

5 Heavily Shorted Stocks Set to Soar on Bullish Earnings

By Roberto Pedone
Mar 1, 2013 2:39 PM EST

Perilous Reversal Watch: Yamana Gold (AUY)

By TheStreet Wire
Feb 25, 2013 12:05 PM EST

Sangamo's HIV Gene Therapy Is a Valuation Prop, Nothing More

By Adam Feuerstein
Feb 25, 2013 10:35 AM EST

CTI Biopharma Posts Positive Myelofibrosis Study Results

By Adam Feuerstein
Nov 27, 2012 6:40 AM EST

5 Stocks Insiders Love Right Now

By Roberto Pedone
Nov 9, 2012 3:47 PM EST

5 Stocks Poised for Breakouts

By Roberto Pedone
Oct 22, 2012 2:36 PM EDT

Inflating Market Bubble Not Quite Ready to Pop

By Roberto Pedone
Oct 10, 2012 1:48 PM EDT

Jim Cramer's 'Mad Money' Recap: Fear and Loathing on Wall Street

By Scott Rutt
Sep 18, 2012 8:11 PM EDT

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest

By Martin Shkreli
Sep 12, 2012 7:08 AM EDT

Earnings Preview: Dow Stocks J&J, Travelers and Verizon Report Premarket Tuesday

By Roberto Pedone
Aug 20, 2012 1:50 PM EDT

Could This Biotech Stock Be First to Break Feuerstein-Ratain Rule?

By Adam Feuerstein
Jul 6, 2012 6:00 AM EDT

Hedge Funds Love These 5 Consumer Stocks -- but Should You?

By Roberto Pedone
Apr 2, 2012 1:01 PM EDT

MannKind Afrezza Contributes to Sanofi's Subpar Diabetes Unit Sales

By Adam Feuerstein
Mar 30, 2012 5:30 AM EDT

5 Hated Earnings Stocks You Should Love

By Roberto Pedone
Mar 23, 2012 2:08 PM EDT

Gilead Sciences Buying Achillion Was Twitter Speculation at Its Finest

By Adam Feuerstein
Mar 23, 2012 5:30 AM EDT

The Next Big Thing in Biotech: FDA Decisions

By Gregg Greenberg
Mar 23, 2012 5:00 AM EDT

Vertex Pharma Cystic Fibrosis FDA Advisory Panel Live Blog

By Adam Feuerstein
Mar 15, 2012 11:54 AM EDT

4 Under-$10 Biotech Stocks in Breakout Territory

By Roberto Pedone
Mar 13, 2012 6:12 AM EDT

Genfit Digs Even Deeper to Find Hidden Benefit in Fatty Liver Drug

By Adam Feuerstein
Feb 29, 2012 7:03 AM EST